{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:49:50Z","timestamp":1792414190207,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012157","name":"Shanghai Key Discipline Construction Project","doi-asserted-by":"publisher","award":["2024ZDXK0013"],"award-info":[{"award-number":["2024ZDXK0013"]}],"id":[{"id":"10.13039\/501100012157","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpha.2025.101264","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:21:03Z","timestamp":1741983663000},"page":"101264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers of bipolar disorder in omics and neuroimaging"],"prefix":"10.1016","volume":"15","author":[{"given":"Donglin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-231X","authenticated-orcid":false,"given":"Zuowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-0655","authenticated-orcid":false,"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101264_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpha.2025.101264_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jad.2018.08.054","article-title":"Association between completed suicide and bipolar disorder: A systematic review of the literature","volume":"242","author":"Plans","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jad.2023.07.060","article-title":"Gender differences in suicide among patients with bipolar disorder: A systematic review and meta-analysis","volume":"339","author":"Hu","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4088\/JCP.v64n0209","article-title":"Perceptions and impact of bipolar disorder: How far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1725","article-title":"Prospective: Is bipolar disorder being overdiagnosed?","volume":"27","author":"Kelly","year":"2018","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1176\/appi.ajp.157.2.220","article-title":"Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features","volume":"157","author":"Tohen","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1176\/appi.ajp.158.8.1265","article-title":"Risk for bipolar illness in patients initially hospitalized for unipolar depression","volume":"158","author":"Goldberg","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jpha.2025.101264_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.21078","article-title":"Candidate biomarkers in psychiatric disorders: State of the field","volume":"22","author":"Abi-Dargham","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.110","article-title":"A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder","volume":"5","author":"Munkholm","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-11674-y","article-title":"Downregulation of long non-coding RNAs in patients with bipolar disorder","volume":"12","author":"Maloum","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101264_bib13","article-title":"IL-4 as a potential biomarker for differentiating major depressive disorder from bipolar depression","volume":"102","author":"Lu","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jpha.2025.101264_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050607","article-title":"Metabolomic profiling of bipolar disorder by (1)H-NMR in Serbian patients","volume":"13","author":"Simi\u0107","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jpha.2025.101264_bib15","first-page":"78","article-title":"Reduced cortical thicknesses of adolescents with bipolar disorder and relationship with brain-derived neurotrophic factor, Scand. J. Child Adolesc. Psychiatr","volume":"11","author":"\u0130nal","year":"2023","journal-title":"Psychol"},{"key":"10.1016\/j.jpha.2025.101264_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.euroneuro.2021.01.097","article-title":"DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network","volume":"47","author":"Kessing","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jpha.2025.101264_bib17","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/schbul\/sbm057","article-title":"Deconstructing bipolar disorder: A critical review of its diagnostic validity and a proposal for DSM-V and ICD-11","volume":"33","author":"Vieta","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpha.2025.101264_bib18","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: A review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jpha.2025.101264_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpha.2025.101264_bib20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5694\/j.1326-5377.2010.tb03889.x","article-title":"Bipolar disorder: Diagnostic issues","volume":"193","author":"Tiller","year":"2010","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jpha.2025.101264_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-0327(94)90028-0","article-title":"Suicide in psychotic major depression","volume":"31","author":"Isomets\u00e4","year":"1994","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jpha.2025.101264_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/joim.12234","article-title":"Biomarkers: Refining diagnosis and expediting drug development-reality, aspiration and the role of open innovation","volume":"276","author":"Salter","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jpha.2025.101264_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/med.21293","article-title":"Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers","volume":"34","author":"Liu","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jpha.2025.101264_bib25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2025.101264_bib26","article-title":"Omics-based biomarkers: Application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpha.2025.101264_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/1570159X13666150307004545","article-title":"A review of biomarkers in mood and psychotic disorders: A dissection of clinical vs. preclinical correlates","volume":"13","author":"Brand","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpha.2025.101264_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02418-1","article-title":"Neurotransmission-related gene expression in the frontal pole is altered in subjects with bipolar disorder and schizophrenia","volume":"13","author":"Medina","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12111476","article-title":"Differential diagnosis of major depressive disorder and bipolar disorder: Genetic and hormonal assessment and the influence of early-life stress","volume":"12","author":"Menezes","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.jpha.2025.101264_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-01938-6","article-title":"A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers","volume":"12","author":"Salvetat","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/jhg.2011.101","article-title":"Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder","volume":"56","author":"Kato","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jpha.2025.101264_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210067","article-title":"RNA biomarkers in bipolar disorder and response to mood stabilizers","volume":"24","author":"Pisanu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101264_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpha.2025.101264_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3004338","article-title":"Circulating hsa-let-7e-5p and hsa-miR-125a-5p as possible biomarkers in the diagnosis of major depression and bipolar disorders","volume":"2022","author":"Gecys","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jpha.2025.101264_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jad.2022.08.034","article-title":"Decreased miR-15b-5p\/miR-155-5p levels and increased miR-134-5p\/miR-652-3p levels among BD patients under lithium treatment","volume":"317","author":"Tekdemir","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib36","first-page":"378","article-title":"Biomarker potential of hsa-miR-145-5p in peripheral whole blood of manic bipolar I patients","volume":"40","author":"Tekin","year":"2022","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/15622975.2021.1907715","article-title":"Transcriptomic profiling as biological markers of depression\u2013A pilot study in unipolar and bipolar women","volume":"22","author":"Dmitrzak-Weglarz","year":"2021","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00109-021-02070-6","article-title":"Dysregulation of circRNA expression in the peripheral blood of individuals with schizophrenia and bipolar disorder","volume":"99","author":"Mahmoudi","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jpha.2025.101264_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94122-7","article-title":"Identification of lncRNA NR_028138.1 as a biomarker and construction of a ceRNA network for bipolar disorder","volume":"11","author":"He","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101264_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00757","article-title":"Plasma microRNA array analysis identifies overexpressed miR-19b-3p as a biomarker of bipolar depression distinguishing from unipolar depression","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00406-019-01057-2","article-title":"A miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls","volume":"270","author":"Tabano","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpha.2025.101264_bib42","article-title":"Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101264_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2018.12.044","article-title":"Significant increasing of DISC2 long non-coding RNA expression as a potential biomarker in bipolar disorder","volume":"696","author":"Naghavi-Gargari","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpha.2025.101264_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2019.10.038","article-title":"Circulating exosomal microRNAs in bipolar disorder","volume":"262","author":"Ceylan","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2019.05.020","article-title":"Preliminary investigation of peripheral extracellular vesicles' microRNAs in bipolar disorder","volume":"255","author":"Fries","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2019.09.060","article-title":"microRNA dysregulation in manic and euthymic patients with bipolar disorder","volume":"261","author":"Camkurt","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2017.06.019","article-title":"Dysregulation of miR-499, miR-708 and miR-1908 during a depression episode in bipolar disorders","volume":"654","author":"Banach","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpha.2025.101264_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib49","doi-asserted-by":"crossref","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101264_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.88","article-title":"Serum proteomic profiling of major depressive disorder","volume":"5","author":"Bot","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2024.01.088","article-title":"Serum neurofilament light as a potential marker of illness duration in bipolar disorder","volume":"350","author":"Queissner","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2024.05.034","article-title":"Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control study","volume":"358","author":"Knorr","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jad.2023.07.079","article-title":"Thiol-disulphide homeostasis, ischemia-modified albumin, complete blood count-derived inflammatory markers and C-reactive protein from acute mania to early remission in bipolar disorder","volume":"339","author":"Korkmaz","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib54","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2023.04.006","article-title":"Ferritin as a potential disease marker in patients with bipolar disorder","volume":"332","author":"Munkholm","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpsychires.2022.10.010","article-title":"Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders","volume":"156","author":"G\u00f3mez de San Jos\u00e9","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpsychires.2022.09.019","article-title":"Elevation of C-reactive protein in adolescent bipolar disorder vs. anxiety disorders","volume":"156","author":"Whitney","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpsychires.2022.04.002","article-title":"Comparison of cognitive impairments with lipid profiles and inflammatory biomarkers in unipolar and bipolar depression","volume":"150","author":"Zhang","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib58","article-title":"Increased hypocretin (orexin) plasma level in depression, bipolar disorder patients","volume":"12","author":"Li","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpsychires.2020.12.051","article-title":"Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder","volume":"134","author":"Idemoto","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112781","article-title":"Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction","volume":"284","author":"Castillo","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jpha.2025.101264_bib61","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcn.12896","article-title":"Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder","volume":"73","author":"Pedrotti Moreira","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpha.2025.101264_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2018.06.037","article-title":"Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis","volume":"202","author":"Loureiro","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/15622975.2016.1155746","article-title":"C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder","volume":"18","author":"Chang","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psyneuen.2017.09.005","article-title":"Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS\/MS and bioinformatics analysis","volume":"86","author":"Ren","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpha.2025.101264_bib65","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1007\/s12035-016-0098-6","article-title":"Ratio of mBDNF to proBDNF for differential diagnosis of major depressive disorder and bipolar depression","volume":"54","author":"Zhao","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpha.2025.101264_bib66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jad.2015.12.020","article-title":"Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder","volume":"192","author":"Scola","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib67","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bdi.12320","article-title":"Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder","volume":"17","author":"Pandey","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpha.2025.101264_bib68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2014.01.006","article-title":"Further evidence for plasma progranulin as a biomarker in bipolar disorder","volume":"157","author":"Kittel-Schneider","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.bp.113.134064","article-title":"Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study","volume":"205","author":"Li","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2014.05.009","article-title":"Comparison of inflammatory cytokine levels among type I\/type II and manic\/hypomanic\/euthymic\/depressive states of bipolar disorder","volume":"166","author":"Bai","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2014.01.009","article-title":"Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts","volume":"160","author":"S\u00f6dersten","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib72","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jpsychires.2009.04.010","article-title":"Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis","volume":"43","author":"Fernandes","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2016.08.004","article-title":"Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders","volume":"32","author":"Galvez-Contreras","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jpha.2025.101264_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpha.2025.101264_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2024.03.114","article-title":"Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder","volume":"356","author":"Wang","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamapsychiatry.2023.4096","article-title":"Metabolomic biomarker signatures for bipolar and unipolar depression","volume":"81","author":"Tomasik","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib77","first-page":"11496","article-title":"8-Iso-prostaglandin F2\u03b1 as a potential biomarker in patients with unipolar and bipolar depression","volume":"27","author":"La\u010dkovi\u0107","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jpha.2025.101264_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050600","article-title":"Application of lipidomics in psychiatry: Plasma-based potential biomarkers in schizophrenia and bipolar disorder","volume":"13","author":"Costa","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jpha.2025.101264_bib79","article-title":"Altered metabolomics in bipolar depression with gastrointestinal symptoms","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib80","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.2147\/NDT.S387063","article-title":"Individuals with bipolar disorder have a higher level of homocysteine than major depressive disorder: A retrospective chart review and observational study","volume":"18","author":"Zhao","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpha.2025.101264_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5717445","article-title":"Metabolomic identification of serum exosome-derived biomarkers for bipolar disorder","volume":"2022","author":"Du","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jpha.2025.101264_bib82","article-title":"Alterations in the plasma lipidome of adult women with bipolar disorder: A mass spectrometry-based lipidomics research","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135515","article-title":"Metabolomic analysis to detect urinary molecular changes associated with bipolar depression","volume":"742","author":"Ren","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpha.2025.101264_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.747595","article-title":"Pre- and post-treatment levels of plasma metabolites in patients with bipolar depression","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97955-4","article-title":"Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: A case-control study","volume":"11","author":"Lu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101264_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105902","article-title":"Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder","volume":"211","author":"Guidara","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jpha.2025.101264_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2075","article-title":"Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study","volume":"11","author":"Kageyama","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.jpha.2025.101264_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.569612","article-title":"Metabolic profiling in bipolar disorder patients during depressive episodes","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib89","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.18632\/aging.101805","article-title":"Urinary metabolite signature in bipolar disorder patients during depressive episode","volume":"11","author":"Chen","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jpha.2025.101264_bib90","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/15622975.2018.1487077","article-title":"Branched-chain amino acids are associated with metabolic parameters in bipolar disorder","volume":"20","author":"Fellendorf","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0664-6","article-title":"Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: A longitudinal case-control study","volume":"9","author":"Knorr","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0378-9","article-title":"Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls","volume":"9","author":"Sellgren","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.psyneuen.2018.09.020","article-title":"Hair cortisol in newly diagnosed bipolar disorder and unaffected first-degree relatives","volume":"99","author":"Coello","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpha.2025.101264_bib94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bdi.12708","article-title":"Serum uric acid as a predictor of bipolarity in individuals with a major depressive episode","volume":"21","author":"Dos Santos Oliveira","year":"2019","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpha.2025.101264_bib95","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpsychires.2019.09.009","article-title":"Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder","volume":"119","author":"Tasic","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ijnp\/pyx089","article-title":"Plasma nervonic acid is a potential biomarker for major depressive disorder: A pilot study","volume":"21","author":"Kageyama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpha.2025.101264_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0183-x","article-title":"Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: A targeted metabolomics study","volume":"8","author":"Pan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.141","article-title":"Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence","volume":"7","author":"Prisciandaro","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/pcn.12461","article-title":"Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis","volume":"71","author":"Kageyama","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpha.2025.101264_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s40345-017-0088-2","article-title":"(1)H-NMR, (1)H-NMR T(2)-edited, and 2D-NMR in bipolar disorder metabolic profiling","volume":"5","author":"Sethi","year":"2017","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib101","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","article-title":"A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics","volume":"258","author":"Ribeiro","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jpha.2025.101264_bib102","first-page":"97","article-title":"Perturbational profiling of metabolites in patient fibroblasts implicates \u03b1-aminoadipate as a potential biomarker for bipolar disorder","volume":"2","author":"Huang","year":"2016","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib103","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1021\/acs.jproteome.5b00434","article-title":"Divergent urinary metabolic phenotypes between major depressive disorder and bipolar disorder identified by a combined GC-MS and NMR spectroscopic metabonomic approach","volume":"14","author":"Chen","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpha.2025.101264_bib104","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.12740\/PP\/OnlineFirst\/42047","article-title":"The serum concentration of magnesium as a potential state marker in patients with diagnosis of bipolar disorder","volume":"49","author":"Siwek","year":"2015","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.jpha.2025.101264_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115221","article-title":"Sex-specific urinary biomarkers for diagnosing bipolar disorder","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101264_bib106","article-title":"Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101264_bib107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-013-3244-0","article-title":"Cortical glutathione levels in young people with bipolar disorder: A pilot study using magnetic resonance spectroscopy","volume":"231","author":"Godlewska","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpha.2025.101264_bib108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S58302","article-title":"Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: A case report","volume":"10","author":"Miura","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jpha.2025.101264_bib109","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/elps.201200632","article-title":"Optimization and validation of a capillary electrophoresis laser-induced fluorescence method for amino acids determination in human plasma: Application to bipolar disorder study","volume":"34","author":"Lorenzo","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpha.2025.101264_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.84","article-title":"A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder","volume":"2","author":"Brady","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib111","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-5618.2012.01040.x","article-title":"Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: A phosphorus-31 magnetic resonance spectroscopy study","volume":"14","author":"Shi","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpha.2025.101264_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jad.2011.01.007","article-title":"Elevated daytime cortisol levels: A biomarker of subsequent major affective disorder?","volume":"132","author":"Ellenbogen","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib113","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0033291799001439","article-title":"Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy","volume":"30","author":"Murashita","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpha.2025.101264_bib114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2023.4150","article-title":"Patterns of neural network functional connectivity associated with Mania\/hypomania and depression risk in 3 independent young adult samples","volume":"81","author":"Schumer","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2023.08.101","article-title":"NIRS-aided differential diagnosis among patients with major depressive disorder, bipolar disorder, and schizophrenia","volume":"341","author":"Chou","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib116","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.biopsych.2022.10.018","article-title":"Differences in quantification of the metabotropic glutamate receptor 5 across bipolar disorder and major depressive disorder","volume":"93","author":"Holmes","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061608","article-title":"Functional connectivity of the anterior cingulate cortex and the right anterior Insula differentiates between major depressive disorder, bipolar disorder and healthy controls","volume":"11","author":"Todeva-Radneva","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpha.2025.101264_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2022.09.016","article-title":"A graph theory neuroimaging approach to distinguish the depression of bipolar disorder from major depressive disorder in adolescents and young adults","volume":"319","author":"Goldman","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib119","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-022-04301-7","article-title":"Differences of resting fMRI and cognitive function between drug-na\u00efve bipolar disorder and schizophrenia","volume":"22","author":"Liang","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jad.2021.09.065","article-title":"The relation of optical coherence tomography findings with oxidative stress parameters in patients with bipolar disorder and unaffected first-degree relatives","volume":"296","author":"Kilicarslan","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib121","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopsych.2019.06.014","article-title":"The electroretinogram may differentiate schizophrenia from bipolar disorder","volume":"87","author":"H\u00e9bert","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib122","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1550059418824824","article-title":"Abnormalities of alpha activity in frontocentral region of the brain as a biomarker to diagnose adolescents with bipolar disorder","volume":"50","author":"Khaleghi","year":"2019","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.jpha.2025.101264_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.102049","article-title":"Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression","volume":"26","author":"Kamintsky","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.jpha.2025.101264_bib124","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41386-019-0485-6","article-title":"Widespread white matter microstructural abnormalities in bipolar disorder: Evidence from mega- and meta-analyses across 3033 individuals","volume":"44","author":"Favre","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpha.2025.101264_bib125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2018.05.017","article-title":"Illness, at-risk and resilience neural markers of early-stage bipolar disorder","volume":"238","author":"Lin","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3654894","article-title":"Choline compounds of the frontal lobe and temporal glutamatergic system in bipolar and schizophrenia proton magnetic resonance spectroscopy study","volume":"2018","author":"Gali\u0144ska-Skok","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jpha.2025.101264_bib127","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1192\/bjp.2018.101","article-title":"Fractional anisotropy of the uncinate fasciculus and cingulum in bipolar disorder type I, type II, unaffected siblings and healthy controls","volume":"213","author":"Foley","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib128","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","article-title":"A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia","volume":"74","author":"Jauhar","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4306\/pi.2017.14.4.471","article-title":"Microstructural abnormalities of basal ganglia and thalamus in bipolar and unipolar disorders: A diffusion kurtosis and perfusion imaging study","volume":"14","author":"Zhao","year":"2017","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.jpha.2025.101264_bib130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpsychires.2015.06.002","article-title":"Subcortical volumes differentiate Major Depressive Disorder, Bipolar Disorder, and remitted Major Depressive Disorder","volume":"68","author":"Sacchet","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpha.2025.101264_bib131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jad.2014.05.051","article-title":"Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: A potential new tool for diagnosis","volume":"167","author":"Shi","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib132","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mp.2011.3","article-title":"New structural brain imaging endophenotype in bipolar disorder","volume":"17","author":"Matsuo","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib133","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2010.07.028","article-title":"Disruption of white matter integrity in bipolar depression as a possible structural marker of illness","volume":"69","author":"Benedetti","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib134","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2008.07.003","article-title":"Temporal lobe volume in bipolar disorder: Relationship with diagnosis and antipsychotic medication use","volume":"114","author":"Jones","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2006.08.023","article-title":"Mania, glutamate\/glutamine and risperidone in pediatric bipolar disorder: A proton magnetic resonance spectroscopy study of the anterior cingulate cortex","volume":"99","author":"Moore","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib136","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.chi.0000159948.75136.0d","article-title":"Reduced amygdalar gray matter volume in familial pediatric bipolar disorder","volume":"44","author":"Chang","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib137","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biopsych.2005.01.002","article-title":"Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses","volume":"57","author":"Haznedar","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib138","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/hbm.22380","article-title":"Amygdala excitability to subliminally presented emotional faces distinguishes unipolar and bipolar depression: An fMRI and pattern classification study","volume":"35","author":"Grotegerd","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jpha.2025.101264_bib139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1148\/radiol.09090339","article-title":"Update on the use of MR for assessment and diagnosis of psychiatric diseases","volume":"255","author":"Agarwal","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jpha.2025.101264_bib140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pharmrev.122.000788","article-title":"Emergence of extracellular vesicles as \u201cliquid biopsy\u201d for neurological disorders: Boom or bust","volume":"76","author":"Kumar","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpha.2025.101264_bib141","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awad341","article-title":"Extracellular vesicle biomarkers for complement dysfunction in schizophrenia","volume":"147","author":"Xue","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.jpha.2025.101264_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jpha.2025.101264_bib143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/YPG.0000000000000327","article-title":"Applications of Mendelian randomization in psychiatry: A comprehensive systematic review","volume":"32","author":"Saccaro","year":"2022","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.jpha.2025.101264_bib144","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.biopsych.2024.02.1005","article-title":"A metabolome-wide mendelian randomization study identifies dysregulated arachidonic acid synthesis as a potential causal risk factor for bipolar disorder","volume":"96","author":"Stacey","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpha.2025.101264_bib145","article-title":"Oxidative stress and psychiatric disorders: Evidence from the bidirectional mendelian randomization study","volume":"11","author":"Lu","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jpha.2025.101264_bib146","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jad.2017.03.052","article-title":"The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines","volume":"217","author":"Malhi","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpha.2025.101264_bib147","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/bdi.12562","article-title":"Why \u2018mood stabilizer\u2019 needs stability: Polar views on its utility","volume":"19","author":"Malhi","year":"2017","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpha.2025.101264_bib148","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bdi.12280","article-title":"Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: A commentary","volume":"17","author":"Pavuluri","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jpha.2025.101264_bib149","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.psychres.2018.08.034","article-title":"The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention","volume":"269","author":"Fornaro","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jpha.2025.101264_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl. Psychiatry"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:19:24Z","timestamp":1766157564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2095177925000814"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101264","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of bipolar disorder in omics and neuroimaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101264"}}